Oncology Today with Dr Neil Love

A new podcast from Research To Practice, a CME group in Miami, Florida

About the show

Medical oncologist Dr Neil Love interviews preeminent oncology clinical investigators on new research, COVID-19 updates and how it all comes together in general medical oncology practice.

Oncology Today with Dr Neil Love on social media

Episodes

  • Oncology Nurse Practitioner Kelly Goodwin Provides a Nurse’s Perspective on Clinical Care for Patients with Lung Cancer at Massachusetts General Hospital During COVID-19

    May 27th, 2020  |  16 mins 4 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, nurses, nursing, oncology, oncology education, oncology nurse, research to practice, telemedicine

    Oncology nurse practitioner Kelly Goodwin discusses current treatment practices at Massachusetts General Hospital, the challenges encountered treating patients with cancer during COVID-19, and the use of telemedicine in oncology care.

  • Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era

    May 19th, 2020  |  19 mins 32 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors.

  • Dr Kathleen Moore Comments on the Management of Ovarian Cancer During the COVID-19 Pandemic

    May 15th, 2020  |  14 mins 26 secs
    brca, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, gynecologic cancer, immunotherapy, metastatic, oncology, oncology education, ovarian cancer, parp, research to practice, telemedicine

    Dr Kathleen Moore from the Stephenson Cancer Center and co-chair of the SGO 2020 Annual Meeting discusses COVID guidelines and the impact of the pandemic on clinical research and the treatment of ovarian cancer.

  • Dr Julie Gralow Comments on Breast Cancer Management in Seattle during the COVID-19 Pandemic

    May 3rd, 2020  |  25 mins 13 secs
    brca, breast cancer, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, er-positive, her2, her2-positive, immunotherapy, metastatic, oncology, oncology education, parp, research to practice, telemedicine

    Dr Julie Gralow reviews how telemedicine and the screening, diagnosis and treatment of breast cancer have rapidly adapted based on resource limitations and risk factors related to COVID-19.

  • AACR Virtual Spectacular: Dr Leora Horn Comments on the New COVID-19 Lung Cancer Registry

    April 29th, 2020  |  13 mins 20 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    Dr Leora Horn of Vanderbilt University Medical Center discusses outcomes for patients with lung cancer and COVID-19 as well as the human implications of social distancing.

  • Dr Harold Burstein on Breast Cancer Treatment and COVID-19 at Dana-Farber

    April 24th, 2020  |  28 mins 50 secs
    brca, breast cancer, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, er-positive, her2, her2-positive, immunotherapy, metastatic, oncology, oncology education, parp, research to practice, telemedicine

    Dr Harold Burstein discusses how breast cancer is currently being managed at the Dana-Farber Cancer Institute with the constraints of social distancing and other COVID-19 considerations.

  • Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle

    April 21st, 2020  |  22 mins 4 secs
    dr neil love, research to practice

    Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations.

  • COVID-19 and Prostate Cancer

    April 9th, 2020  |  16 mins 16 secs
    dr neil love, research to practice

    COVID-19 and prostate cancer treatment with Drs Neeraj Agarwal, Emmanuel S Antonarakis and A Oliver Sartor.